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Editorial: Lung Cancer Screening
YOSHIHIRO HAYATA
Tokyo Medical College Cancer Center, Tokyo, Japan
The review paperby Dr. Denis A. Cortese on "Lung Cancer
Screening: Current Status in the United States" is an im-
portant description of the history and present situation of
screening for lung cancer in the United States. Screening
for lung cancer in the United States was halted after the
three huge studies carded out in the 1970s by the Mayo
Clinic, Memorial Sloan-Kettering Medical Center, and
Johns Hopkins, because the results, although yielding a
high detection rate of lung cancer, did not demonstrate a
higher survival rate or cost-effective benefit.
Tokyo Medical College has been carrying out chest x-
ray surveys for chest diseases on employees of the Tokyo
Metropolitan Government since 1953, which makes it the
longest continuously performed chest x-ray survey in the
world. However, this is not a prospective randomized
study, and the age of the oldest participants is limited by
the retirement age of the metropolitan employees.
Looking at the cases of cancer detected in this group,
41.9% were stage I, 13.7% were stage II, and 44.4% were
stages III and IV. The resectability rates were 18.3, 66.7,
and 30.2%, respectively. A high-risk group was estab-
lished approximately 20 years ago, consisting of those
aged 45 or more and with a cigarette index (number of
cigarettes per day times number of years smoking) of400
or more, and these subjects were offered a semiannual sur-
vey. The rate of early-stage lung cancer detection in the
semiannual group was 24.3%, compared with only 11.1%
in the annual group and 10.3% in the group which had not
received an examination in the previous year. These sta-
tistics show that, in the Japanese experience, screening
certain high-risk groups is beneficial in terms ofdetection
at an early stage, curative resection, prognosis, and also
cost-beneficial treatment.
The Japanese experience does suggest that the studies
described at the end of Dr. Cortese’s paper will in fact
show that chest x-rays are valuable in lung cancer screen-
ing and may even lead to attempts to use bronchoscopy as
a screening method in certain very high-risk groups. In
the case of gastric and esophageal cancer, the idea of en-
doscopic screening was initially rejected, but later stud-
ies showed that it is a valid approach, given an appropriate
risk factor. It may well be that the studies described by Dr.
Cortese will lead to an endoscopic approach to screen sub-
jects at particularly high risk of developing lung cancer.